We are live on ! Find out more
JAZZ icon

Jazz Pharmaceuticals
JAZZ

234 hedge funds and large institutions have $3.41B invested in Jazz Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 234 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

57% less call options, than puts

Call options by funds: $26.3M | Put options by funds: $60.9M

Holders
234
Holders Change
+234
Holders Change %
–
% of All Funds
7.64%
Holding in Top 10
10
Holding in Top 10 Change
+10
Holding in Top 10 Change %
% of All Funds
0.33%
New
234
Increased
–
Reduced
–
Closed
–
Calls
$26.3M
Puts
$60.9M
Net Calls
-$34.6M
Net Calls Change
-$34.6M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
RA
51
Royce & Associates
New York
$12.6M +$11.2M +184,000 New
EA
52
Emerald Advisers
Pennsylvania
$12.1M +$10.8M +176,648 New
American Century Companies
53
American Century Companies
Missouri
$11.8M +$10.5M +171,852 New
California Public Employees Retirement System
54
California Public Employees Retirement System
California
$10.7M +$9.51M +155,660 New
JP Morgan Chase
55
JP Morgan Chase
New York
$10.3M +$9.2M +150,546 New
CS
56
Credit Suisse
Switzerland
$10.2M +$9.07M +148,359 New
PC
57
Polar Capital
United Kingdom
$10.1M +$8.99M +147,046 New
Norges Bank
58
Norges Bank
Norway
$10.1M +$8.98M +146,912 New
Renaissance Technologies
59
Renaissance Technologies
New York
$10.1M +$8.97M +146,800 New
VCAM
60
Valentine Capital Asset Management
California
$9.64M +$8.57M +140,194 New
RFC
61
Russell Frank Company
Washington
$9.29M +$8.27M +135,241 New
Citadel Advisors
62
Citadel Advisors
Florida
$9M +$8M +130,921 New
Susquehanna International Group
63
Susquehanna International Group
Pennsylvania
$8.94M +$7.95M +130,015 New
CCM
64
Cadence Capital Management
Massachusetts
$8.89M +$7.91M +129,346 New
GC
65
Gratry & Company
Ohio
$8.34M +$7.41M +121,280 New
OAM
66
Origin Asset Management
United Kingdom
$8.32M +$7.4M +120,991 New
Two Sigma Investments
67
Two Sigma Investments
New York
$7.82M +$6.96M +113,828 New
Allianz Asset Management
68
Allianz Asset Management
Germany
$7.74M +$6.89M +112,642 New
DCM
69
Dupont Capital Management
Delaware
$7.43M +$6.6M +108,058 New
BGIM
70
Brandywine Global Investment Management
Pennsylvania
$7.38M +$6.57M +107,426 New
U
71
UBS
Switzerland
$7.27M +$6.46M +105,764 New
Balyasny Asset Management
72
Balyasny Asset Management
Illinois
$7.16M +$6.37M +104,152 New
DCM
73
Driehaus Capital Management
Illinois
$6.94M +$6.17M +101,009 New
AIG
74
American International Group
New York
$6.63M +$5.9M +96,465 New
California State Teachers Retirement System (CalSTRS)
75
California State Teachers Retirement System (CalSTRS)
California
$6.21M +$5.52M +90,365 New
1 2
3
4 5

JAZZ Hedge Fund Activity: Q2 2013 in Review

234 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Jazz Pharmaceuticals (JAZZ) for Q2 2013, worth a combined $3.41B.

Buyers outnumbered sellers: 234 funds opened new JAZZ positions and 0 closed out — a net gain of 234 holders — while 0 added to existing stakes and 0 trimmed.

  • 234 institutional investors held Jazz Pharmaceuticals (JAZZ) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $3.41B of Jazz Pharmaceuticals stock for Q2 2013.
  • 234 funds opened new Jazz Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +234 holders.

Based on aggregated 13F filings for Q2 2013.